NK cell immunotherapy: what’s next in clinical development?
European Pharmaceutical Review
DECEMBER 12, 2023
Pharmaceutical companies such as Sanofi and AstraZeneca are currently conducting several high-potential clinical development programmes in oncology in collaboration with Innate Pharma. He is a member of the company’s Executive Board. Innate Pharma has also partnered with Takeda to develop an antibody drug conjugate (ADC).
Let's personalize your content